Release of the protein molecule, leukocytic pyrogen, is one of the many reactions exhibited by leukocytes after phagocytosis. After the ingestion of heat-killed S. albus, a 3–4 hr latent period exists, during which human peripheral leukocytes release no pyrogen, yet cellular metabolism is altered in such a way that pyrogen output may subsequently occur in the absence of further phagocytosis. Transcription of messenger RNA and translation of new protein are initial events in the. activation process, since addition of the inhibitors, actinomycin D, and cycloheximide or puromycin, during this period markedly depressed or abolished subsequent pyrogen release. These effects were noted to be dependent upon the time of addition of the inhibitors. None of the inhibitor drugs interfered with cell viability as measured by phagocytosis and hexose monophosphate shunt activity, nor did they alter the pyrogenicity of preformed leukocytic pyrogen. Vincristine did not inhibit pyrogen formation, consistent with its reported failure to alter RNA synthesis in mature human granulocytes. The glycolytic inhibitor, sodium fluoride, blocked pyrogen release both when added prior to particle ingestion or 1 hr after the initiation of phagocytosis. Whereas inhibition of phagocytosis would explain the sodium fluoride effect prior to 1 hr, this was not observed in leukocyte preparations incubated for 1 hr with S. albus before adding sodium fluoride. When sodium fluoride was added to preparations 2 hr after the start of incubation, the LP production was unimpaired. Potassium cyanide had no effect on cell activation or pyrogen release. These findings suggest that the primary energy supply for the activation process is derived from high energy phosphate bonds provided by anaerobic glycolysis. Since the major amount of cell activation appears to occur in the 1st hr after phagocytosis, this energy might be involved in the induction of a genome leading to the transcription of m-RNA and its translation into new protein or is required for polysome integrity during protein synthesis. It is suggested that this new protein may be leukocytic pyrogen itself, or an enzyme responsible for cleaving it from an inactive precursor.
Skip Nav Destination
Article navigation
1 April 1970
Article|
April 01 1970
STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN
James J. Nordlund,
James J. Nordlund
From the Department of Health, Education, and Welfare, National Institutes of Health, National Cancer Institute, Medicine Branch, and National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigation, Bethesda, Maryland 20014
Search for other works by this author on:
Richard K. Root,
Richard K. Root
From the Department of Health, Education, and Welfare, National Institutes of Health, National Cancer Institute, Medicine Branch, and National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigation, Bethesda, Maryland 20014
Search for other works by this author on:
Sheldon M. Wolff
Sheldon M. Wolff
From the Department of Health, Education, and Welfare, National Institutes of Health, National Cancer Institute, Medicine Branch, and National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigation, Bethesda, Maryland 20014
Search for other works by this author on:
James J. Nordlund
From the Department of Health, Education, and Welfare, National Institutes of Health, National Cancer Institute, Medicine Branch, and National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigation, Bethesda, Maryland 20014
Richard K. Root
From the Department of Health, Education, and Welfare, National Institutes of Health, National Cancer Institute, Medicine Branch, and National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigation, Bethesda, Maryland 20014
Sheldon M. Wolff
From the Department of Health, Education, and Welfare, National Institutes of Health, National Cancer Institute, Medicine Branch, and National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigation, Bethesda, Maryland 20014
Received:
October 09 1969
Online ISSN: 1540-9538
Print ISSN: 0022-1007
Copyright © 1970 by The Rockefeller University Press
1970
J Exp Med (1970) 131 (4): 727–743.
Article history
Received:
October 09 1969
Citation
James J. Nordlund, Richard K. Root, Sheldon M. Wolff; STUDIES ON THE ORIGIN OF HUMAN LEUKOCYTIC PYROGEN . J Exp Med 1 April 1970; 131 (4): 727–743. doi: https://doi.org/10.1084/jem.131.4.727
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement